TargetMol

D-JNKI-1 acetate

Product Code:
 
TAR-T10937L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T10937L-1mg1mg£205.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-5mg5mg£335.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-10mg10mg£465.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-25mg25mg£701.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-50mg50mg£970.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-1mL1 mL * 10 mM (in DMSO)£1,042.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10937L-100mg100mg£1,259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
D-JNKI-1 acetate is a highly potent and cell-permeable peptide inhibitor of JNK.
CAS:
0
Formula:
C166H290N66O42
Molecular Weight:
3882.5
Pathway:
MAPK
Purity:
0.9948
SMILES:
CC(C[C@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N1CCC[C@@H]1C(N[C@@H](C(N[C@@H](C(N2CCC[C@@H]2C(N[C@@H](C(N3CCC[C@@H]3C(N4CCC[C@@H]4C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(NCC(N)=O)=O)CCCNC(N)=N)=O)CCCCN)=O)CCCCN)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)=O)=O)CCCNC(N)=N)=O)=O)CCCCN)=O)CCCNC(N)=N)=O)=O)[C@@H](O)C)=O)[C@@H](O)C)=O)CC(C)C)=O)CC(N)=O)=O)NC([C@H](NC([C@H]5CCCN5C([C@H](NC([C@@H](C(C)C)NC([C@H]6CCCN6C([C@H](NC([C@H](NC([C@H](NC([C@@H](CC(O)=O)N)=O)CCC(N)=O)=O)CO)=O)CCCNC(N)=N)=O)=O)=O)CCC(N)=O)=O)=O)Cc7ccccc7)=O)C.CC(O)=O
Target:
JNK

References

1. Kersting S, et al. The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium. J Inflamm Res. 2013 May 3;6:71-81.